Smruthi Organics Announces Positive Financial Results for Q1 2024

Smruthi Organics, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.

According to the financial report, Smruthi Organics has shown a flat performance in the quarter, with a score of 5 compared to -20 in the previous 3 months. However, there are some positive aspects to the company's financials.

One of the key highlights is the growth in Profit Before Tax (PBT) less Other Income, which has increased by 140.7% to Rs 2.13 crore compared to the average PBT of the previous four quarters at Rs 0.89 crore. This indicates a very positive trend in the near term.

Similarly, the Profit After Tax (PAT) has also shown a significant growth of 120.3% to Rs 1.52 crore compared to the average PAT of the previous four quarters at Rs 0.69 crore. This is another positive sign for the company's financials.

In terms of sales, Smruthi Organics has recorded its highest net sales in the last five quarters at Rs 39.66 crore. This is a 27.2% increase over the average net sales of the previous four quarters at Rs 31.19 crore. The near term sales trend is also positive for the company.

Overall, while the financial performance of Smruthi Organics may not be outstanding, there are some positive indicators that show potential for growth in the near future. Investors should keep an eye on the company's progress and make informed decisions.